|
|
|
|
FOCUS ON ANALYTICS & QUALITY |
|
|
|
By Pankaj Singh, Global Market Insights | High-performance liquid chromatography offers more features compared to other analytical techniques, and the industry is finding more valuable ways to use it. |
|
|
|
|
|
ANALYTICS & QUALITY SOLUTIONS |
|
|
|
|
|
| The final agenda is now live! Register now to save 10% off your pass to BioProcess International Conference & Exhibition (September 23-26, 2024, Boston) and experience the next-generation platforms and processes with the people that empower you to deliver transformative therapies with precision, quality and scalability. Use promo code: 2024BO10 to save an additional 10% off your pass. |
|
|
|
|
By John W.M. Claud, Hyman, Phelps & McNamara | Ready or not, when the FDA inspector arrives, the test has already started. New final guidance makes clear what the agency considers an attempt to stonewall. |
|
|
| To GMP Or Not To GMP? That Is The (Plasmid) Question | Article | By Eric Gudorf and Erika Morris, Ajinomoto Bio-Pharma Services | As critical raw materials for viral vector production, plasmids are in high demand. Finding an experienced, GMP-grade plasmid supplier for your process can mitigate risk and yield reliable results. |
|
|
|
|
|
| Complex protein-based therapies don’t play by the same process-engineering rules as small molecules and traditional biologics. They require developers to see the unforeseen and embrace new roles and responsibilities in sourcing raw materials and outsourced expertise. Successful developers can’t let this winding road slow their time to IND. Join Bioprocess Online Live on August 8th for an interactive discussion on early workflow considerations for complex protein-based therapeutics. Supported by Thermo Fisher Scientific. |
|
|
| Connect With Bioprocess Online: |
|
|
|
